Home » Newsletters » BioWorld Science

BioWorld Science

June 13, 2022

View Archived Issues

University of Southampton patents new HIF inhibitors

Gepotidacin shows efficacy in nonhuman primate model of pneumonic plague

CyanVac's CVXGA-1 provides broad protection against SARS-CoV-2 strains in hamster model

Chinese investigators disclose TYK2 inhibitors

FOCAD loss-of-function mutations linked to pediatric liver cirrhosis

Foghorn Therapeutics identifies new PROTACs

Exosomal miR-144-3p identified as potential biomarker of SLE activity

Roche synthesizes new HBV antivirals

TSHZ3 variants tied to CAKUT

Ziphius and University of Antwerp collaborate on delivery of saRNA-based drugs and therapeutics

Otsuka collaborates with xFOREST to create RNA structure-targeted drugs

Biallelic variants in the GTF3C3 gene cause autosomal recessive intellectual disability

Evgen collaborates with University of Michigan to evaluate SFX-01 in models of colorectal cancer

Oxford BioTherapeutics collaborates with ImmunoGen on first-in-class ADCs

At EHA 2022, insights into multiple reasons for marrow failure

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...